ClinicalTrials.gov
ClinicalTrials.gov Menu

Macrophagic Activation and Immunophenotypic Profile of Patients With Gaucher's Disease (Gaucher)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01206673
Recruitment Status : Completed
First Posted : September 22, 2010
Last Update Posted : December 2, 2011
Sponsor:
Information provided by (Responsible Party):
Nantes University Hospital

Brief Summary:
The aim of this study is to evaluate macrophaging activity and immunologic profile of patients with Gaucher 's disease. For this, one blood sampling will be performed.

Condition or disease Intervention/treatment Phase
Patients With Gaucher's Disease Other: Blood sampling Not Applicable

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 10 participants
Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Basic Science
Official Title: Evaluation of Macrophagic Activation and Immunophenotypic Profile of Patients With Gaucher's Disease.
Study Start Date : December 2009
Actual Primary Completion Date : July 2011
Actual Study Completion Date : July 2011

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Gaucher Disease


Intervention Details:
  • Other: Blood sampling
    One blood sampling is required for the research


Primary Outcome Measures :
  1. To determine the implication of acquired and inherent immunity in the Gaucher's clinical phenotype at moment of blood sampling

Secondary Outcome Measures :
  1. to find new activity mark for Gaucher's disease by studying macrophagic activation's markers.


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Adults (age equal or above 18.
  • Patients with Gaucher 's disease treated in the "Grand Ouest" competence center
  • patients affiliated to social security
  • Informed consent signed

Exclusion Criteria:

- Children (age<18)


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01206673


Locations
France
Nantes Hospital
Nantes, France, 44093
CHU of Rennes
Rennes, France, 35
Sponsors and Collaborators
Nantes University Hospital

Responsible Party: Nantes University Hospital
ClinicalTrials.gov Identifier: NCT01206673     History of Changes
Other Study ID Numbers: 09/07-I
First Posted: September 22, 2010    Key Record Dates
Last Update Posted: December 2, 2011
Last Verified: December 2011

Additional relevant MeSH terms:
Gaucher Disease
Sphingolipidoses
Lysosomal Storage Diseases, Nervous System
Brain Diseases, Metabolic, Inborn
Brain Diseases, Metabolic
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Metabolism, Inborn Errors
Genetic Diseases, Inborn
Lipidoses
Lipid Metabolism, Inborn Errors
Lysosomal Storage Diseases
Metabolic Diseases
Lipid Metabolism Disorders